Consensus MorphoSys AG

Equities

MOR

DE0006632003

Market Closed - Xetra Other stock markets 11:38:05 2024-04-18 am EDT			Pre-market 01:32:00 am
67.7 ^EUR	0.00%		67.72	+0.04%

Apr. 11	Health Care Slips on Risk Bias -- Health Care Roundup	DJ
Apr. 11	Trending : Novartis Begins Tender Offer for MorphoSys Shares	DJ

Evolution of the average Target Price on MorphoSys AG

Price target over the last 5 years

History of analyst recommendation changes

f138ad3b9f88ba52.L6BQL5Uv0rBA8mrR1-26Z2I1b6NHgtftme0qu3IPS7s.RZEpYPRGqvMugFL8vqjJCQlgJOIOr43e48Bv9RtYJ-F_zwBp8F2T1wLLXg~aa1e2312597232b8df4d25307c386c4b

Analyst Recommendations on MorphoSys AG

Trending : Novartis Begins Tender Offer for MorphoSys Shares	Apr. 11	DJ
MORPHOSYS : UBS sticks Neutral	Feb. 16	ZD
Novartis' Midterm Sales Growth Prospects Limited as Patent Expirations Loom, Berenberg Says	Feb. 14	MT
MORPHOSYS : UBS revises his opinion and turns to Neutral	Feb. 07	ZD
MORPHOSYS : UBS remains its Buy rating	Feb. 07	ZD
Swiss Market Index Blinks Red Amid Renewed Rate Jitters	Feb. 06	MT
North American Morning Briefing : Rate Doubts Keep Pressure on Stocks; More Earnings in Focus	Feb. 06	DJ
MORPHOSYS : UBS reiterates its Buy rating	Feb. 06	ZD
European Midday Briefing : Stocks Higher But Gains Capped On Rate Doubts	Feb. 06	DJ
MORPHOSYS : JP Morgan reaffirms its Buy rating	Feb. 05	ZD
MORPHOSYS : UBS reiterates its Buy rating	Feb. 05	ZD
MORPHOSYS : Deutsche Bank sticks Neutral	Jan. 31	ZD
MORPHOSYS : JP Morgan gives a Buy rating	Jan. 30	ZD
UBS reiterates Morphosys at 'Buy' - Target 47 euros	Jan. 30	DP
MORPHOSYS : UBS remains its Buy rating	Jan. 30	ZD
MORPHOSYS : UBS reiterates its Buy rating	Jan. 29	ZD
Lower Bank Earnings, Higher Interest Rates Weigh on Exchange-Traded Funds, Equity Futures Pre-Bell Tuesday	Jan. 16	MT
MORPHOSYS : JP Morgan reiterates its Buy rating	Jan. 15	ZD
MORPHOSYS : Receives a Buy rating from JP Morgan	Jan. 02	ZD
MORPHOSYS : Gets a Neutral rating from Goldman Sachs	Dec. 19	ZD
Wells Fargo Adjusts MorphoSys' Price Target to $17 From $10, Keeps Overweight Rating	Dec. 15	MT
MORPHOSYS : Deutsche Bank reiterates its Neutral rating	Dec. 15	ZD
MORPHOSYS : JP Morgan gives a Buy rating	Dec. 14	ZD
MORPHOSYS : Goldman Sachs sticks Neutral	Dec. 12	ZD
MORPHOSYS : UBS gives a Buy rating	Dec. 11	ZD

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

67.7 EUR

Average target price

58.71 EUR

Spread / Average Target

-13.27%

High Price Target

68 EUR

Spread / Highest target

+0.44%

Low Price Target

31 EUR

Spread / Lowest Target

-54.21%

Consensus detail

Consensus revision (last 18 months)

Analysts covering MorphoSys AG

UBS	Xian Deng
JPMORGAN	James Gordon
DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
GOLDMAN SACHS	Rajan Sharma
Wells Fargo Securities
JPMorgan Chase
MORGAN STANLEY	James Quigley
BERENBERG	Xian Deng
DEUTSCHE BANK	Rajan Sharma
BARCLAYS	Brian Balchin
Deutsche Bank Securities
Commerzbank
STIFEL	Marcus Wieprecht
SVB Leerink
Bryan, Garnier & Co.
INDEPENDENT RESEARCH	Tobias Gottschalt
RBC	Charles Weston
HSBC	Julie Mead

Ratings for MorphoSys AG

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar